Extracellular vesicles (EVs) have emerged as promising biomarkers in liquid biopsy, owing
to their ubiquitous presence in bodily fluids and their ability to carry disease-related cargo …

Background Tumor heterogeneity and lack of personalized prognosis leads to bladder
cancer (BlCa) patients' lifelong surveillance with invasive interventions, highlighting the …

Introduction Cell-free DNA (cfDNA), an extracellular free DNA released into the bloodstream
by cells, is a potentially useful noninvasive marker to detect human malignancies and …

Cell-free DNA (cfDNA) testing is the core of most liquid biopsy assays. In particular, cfDNA
fragmentation features could facilitate non-invasive cancer detection due to their …

Simple Summary An early assessment of response to treatment is crucial to informing
appropriate therapeutic management. Using a plasma-only strategy, we measured changes …

The detection of tumor biomarkers in liquid biopsies requires high sensitivity and low-cost
biosensing strategies. However, few traditional techniques can satisfy the requirements of …

Simple Summary Liquid biopsy (LBx) is a novel and promising approach in precision
medicine, suitable for patient management in a wide range of medical conditions. Its utility in …

Methods: In the following article we summarized important aspects from the studies listed in
database PubMed using keywords “circulating, cell-free DNA, RNA, ncRNAs, microRNAs …

Acute aortic syndromes and other acute aortic events are commonly misdiagnosed and
associated with high mortality and morbidity. There is need for a blood-based biomarker to …

Introdução: Os cancros da mama (CaMa), pulmão (CaPl), coloretal (CaCr) e próstata (CaP)
são os quatro cancros mais incidentes a nível mundial para ambos os sexos. Apesar de os …